New study tests smart glucose monitor for insulin users in saudi arabia
NCT ID NCT07603284
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study looks at whether using a real-time continuous glucose monitor (CGM) can help adults with Type 2 diabetes who take insulin better manage their blood sugar levels. About 200 participants in Saudi Arabia will use the Dexcom CGM for up to 24 weeks. The main goal is to see if their HbA1c (a measure of average blood sugar) improves.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES ON INSULIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King Fahad Medical City
Riyadh, Saudi Arabia
Conditions
Explore the condition pages connected to this study.